Drosophila neuroblasts are a model system for studying asymmetric cell division. Neuroblasts bud off a series of smaller progeny, called ganglion mother cells (GMCs). An essential regulator of GMC development is the Prospero homeodomain transcription factor: Prospero is asymmetrically localized to the basal cortex of the mitotic neuroblast and partitioned into the newborn GMC. Prospero is translocated into the GMC nucleus, where it is necessary to establish GMC-specific gene expression. Cortical localization of Prospero protein is observed only during mitosis; cortical localization requires entry into mitosis and cortical delocalization requires exit from mitosis. The tight correlation and functional requirement between mitosis and cortical Prospero localization suggests that mitosis-specific posttranslational modifications may be involved in regulating Prospero subcellular localization. Here we use monoclonals recognizing the N-terminal or C-terminal region of Prospero to explore its posttranslational regulation. One-and two-dimensional Western analysis reveal a complex pattern of Prospero isoforms; phosphatase assays show that there are several phosphoisoforms of Prospero. Developmental 2D Western blots, cell fractionation assays, and analysis of a missense prospero mutation show that cortical Prospero protein is highly phosphorylated compared to nuclear Prospero protein. Our results are consistent with two functions of Prospero phosphorylation: (i) phosphorylation may be required for Prospero cortical localization; or (ii) phosphorylation may be a consequence of Prospero cortical localization, in which case it may facilitate subsequent events, such as Prospero cortical release or nuclear localization.
INTRODUCTION
The asymmetric localization of RNAs or proteins during cell division can be used to create molecular and developmental differences between daughter cells derived from a single precursor. This process has been documented in a wide variety of organisms, including Bacillus subtilis (Jenal and Stephens, 1997) , Caulobacter (Brun et al., 1994) , Saccharomyces cerevisiae (Bobola et al., 1996; Long et al., 1997; Sil and Herskowitz, 1996; Takizawa et al., 1997) , and Caenorhabditis elegans (Guenther and Garriga, 1996; Guo and Kemphues, 1996; Watts et al., 1996) . Recently, the Drosophila central nervous system (CNS) has emerged as a model system for studying asymmetric cell division and protein localization (Broadus and Doe, 1997; Broadus et al., 1998; Doe and Spana, 1995; Hirata et al., 1995; IkeshimaKataoka et al., 1997; Knoblich et al., 1995; Kraut and Campos-Ortega, 1996; Li et al., 1997; Shen et al., 1997 Shen et al., , 1998 Spana and Doe, 1995; Fuerstenberg et al., 1998. The Drosophila CNS develops from a neuroectoderm with an apical/basal polarity (Knust, 1994; Spana and Doe, 1995) . Individual neuroectodermal cells delaminate basally into the embryo, where they enlarge into CNS precursors (neuroblasts) and initiate a stem cell-like division pattern. Each neuroblast divides repeatedly to bud off a series of smaller progeny from its basal surface, called ganglion mother cells (GMCs) . The two daughter cells from a neu-roblast division are different in position, size, mitotic potential, and gene expression: the neuroblast is always apical, larger, and mitotically active and expresses "neural precursor" genes; the GMC is basal and smaller, divides only once, and expresses a different set of genes (reviewed in Goodman and Doe, 1993) . Thus, the neuroblasts undergo a classic asymmetric division to produce siblings with strikingly different fates.
The earliest known regulator of GMC identity is the Prospero homeodomain transcription factor. Prospero is detected in the nucleus of GMCs, where it promotes expression of GMC-specific genes and repression of neuroblast-specific genes Vaessin et al., 1991) . Neuroblasts contain high levels of prospero RNA, but the mRNA is not translated efficiently, and what little protein is produced accumulates in the apical cytoplasm and cell cortex during interphase. As the neuroblast enters mitosis, Prospero protein rapidly becomes tightly associated with the basal cell membrane (hereafter called "cortical localization") and is partitioned specifically into the GMC where it is translocated into the nucleus.
Regulation of Prospero asymmetric cortical localization is complex, requiring several other asymmetrically localized proteins, an intact microfilament cytoskeleton, and cell cycle control. Miranda is a recently identified "coiledcoil" protein that is colocalized with basal Prospero protein, binds Prospero in yeast two hybrid and column assays, is required for Prospero basal localization, and is implicated in regulating the cortical release of Prospero in the GMC (Ikeshima-Kataoka et al., 1997; Shen et al., 1997 Shen et al., , 1998 . Both Miranda and Prospero basal localization require Inscuteable, a putative ankyrin repeat/SH3-binding domain protein localized to the apical cortex of neuroblasts (Ikeshima-Kataoka et al., 1997; Shen et al., 1997) . In addition, Prospero basal localization and/or anchoring requires microfilaments (Broadus and Doe, 1997) . Finally, Prospero basal cortical localization is cell cycle regulated: it only occurs during mitosis and is dependent on entry into mitosis, and delocalization requires exit from mitosis (Knoblich et al., 1995; Spana and Doe, 1995; Broadus and Doe, 1997) .
Little is known about the biochemical modifications that may regulate Miranda/Prospero basal localization, anchoring, or release at the cell cortex. The tight correlation and functional requirement between mitosis and basal Miranda/Prospero localization suggests that mitosisspecific posttranslational modifications of Prospero (or associated proteins) may be involved in regulating basal localization during mitosis. Here we investigate the biochemical properties of the Prospero protein, with the goal of identifying differences between the cortical and nuclear proteins that will shed light on the mechanisms of Prospero subcellular localization. We use developmental 2D Westerns, cell fractionation, and a prospero missense mutation to show that cortical Prospero protein is highly phosphorylated relative to nuclear Prospero protein.
MATERIALS AND METHODS

Fly Stocks
Oregon R fly stocks were maintained at 25°C in large population cages with approximately 4 -5 g of flies/cage. Eggs were collected on grape juice/agar media supplemented with yeast paste. prospero 17 is a null mutation ; prospero I13 is a protein positive EMS allele generated in a saturation mutagenesis of the third chromosome (J.B.S. and C.Q.D., unpublished data).
Identification of Homozygous Mutant Embryos
Homozygous prospero 17 or prospero I13 embryos were identified by lack of ftzlacZ expression (the balancer chromosome marker). Embryos were dechorionated, washed with water, transferred into an equal volume of heptane and 80% ethanol, and devitellinized by shaking vigorously for 30 s. Embryos were washed two times with 80% ethanol and then washed with Ptx (1ϫ PBS, 0.1% Triton ϫ-100) for 30 min. One milliliter of X-gal buffer (10 mM PO 4 buffer, pH 7.2, 150 mM NaCl, 1 mM MgCl 2 , 3 mM K 4 [FeII(CN)6], 3 mM K 3 [FeIII(CN)6]) and 20 l of 10% X-gal solution in DMSO were added for the reaction and the mixture was incubated at 37°C for 2 to 4 h until the ftzlacZ pattern was detectable. Hand-picked mutant embryos were processed for Western blotting as described below.
Monoclonal Antibody Generation
The Prospero C-terminal mouse monoclonal MR1a was generated as previously described . The Prospero N-terminal rat monoclonal P3D4 was generated by immunizing rats with the N-terminal peptide TNASIPGSAHSSHSHQGVSP-KGSRRVSA coupled to keyhole limpet hemocyanin (KLH); rats were boosted twice, after which the diluted raw sera showed a Prospero staining pattern on fixed embryos. The rat was then sacrificed for monoclonal antibody production. Six hundred hybridoma lines were screened on fixed Drosophila embryos at a 1:1 dilution. None of the lines showed a Prospero staining pattern, although several had extremely high "background" staining. The 600 lines were then screened by ELISA against peptide-bovine serum albumin (BSA) conjugate and 29 positives were detected. Five lines with the highest ELISA scores were expanded and tested at multiple concentrations for embryo staining. One line, P3D4, showed the Prospero staining pattern on fixed embryos at 1:10 dilution, but severe background at 1:5 or 1:1. P3D4 was subcloned by limiting dilution and P3D4-1-F10 and P3D4-2-D4 were saved.
Immunoblotting and Immunohistochemistry
For immunoblotting, embryos from various stages of development were collected from grape juice/agar plates, dechorionated for 90 s in a 50% bleach solution, rinsed extensively with water, blotted dry, and hand picked based on stage of development. Embryos were homogenized directly into 2ϫ SDS sample buffer and boiled for 5 min, and proteins were separated by 1D or 2D polyacrylamide gel electrophoresis. For 2D electrophoresis, the ampholyte composition was modified for optimal separation of Prospero protein isoforms: 37.5% pH 4 -6 ampholytes; 37.5% pH 5-8 ampholytes; 25% pH 3-10 ampholytes in a 2% final concentration. For the second dimension whereby the proteins are separated based on their molecular weight, a stacking gel was not used. Two-dimensional SDS-PAGE isoelectric point standards (Bio-Rad Laboratories) were run in parallel and electrophoretically transferred onto PVDF membrane for every experiment as a calibration control to test the reproducibility of the ampholyte range among different experiments. Proteins for both 1D and 2D electrophoresis were performed using an 8% polyacrylamide mini gel (Hoefer Scientific Instruments). Electrophoretic transfer of proteins onto PVDF membrane (Bio-Rad Laboratories) was performed using 0.1% SDS in the transfer buffer. The PVDF membrane was probed with a 1:3 dilution of MR1a mouse anti-Prospero or 1:2 dilution of P3D4 rat anti-Prospero or 1:5000 dilution of anti-␣-tubulin; detection was with 1:2000 dilution of peroxidase-conjugated anti-mouse or antirat secondary antibody (Jackson Laboratories). All primary and secondary antibody dilutions were performed using PBS/0.1% Tween 20 containing 5% nonfat dried milk. Immunoblots were developed using enhanced chemiluminescence according to manufacturer's instructions (Pierce).
For immunohistochemistry, embryos were stained with MR1a mouse anti-Prospero at a 1:4 dilution. Immunohistochemistry was performed by standard methods ; embryos were digitally imaged with a Zeiss Axioplan microscope/Sony CCD camera or with a Bio-Rad 1024 confocal microscope and arranged in Photoshop.
Phosphatase Assay
Embryos were dechorionated in a 50% bleach solution and homogenized in lysis buffer (10 mM Pipes at pH 6.1; 2.5 mM MgCl 2 ; 100 mM NaCl; 0.05% NP-40; 1 mM PMSF; 2 mg/ml aprotinin; 2 mg/ml pepstatin; 1 mM DTT), containing 0.6 mg/ml PAP (Boehringer Mannheim) in the presence or absence of 3 mM sodium vanadate and 20 nM microcystin and incubated at 37°C for 40 or 60 min. The reactions were stopped by addition of 2ϫ SDS sample buffer or 2-D buffer and processed for 1D or 2D Western blots.
Purification of Drosophila Nuclei
Three-to 12-h embryos were pulverized in liquid nitrogen, transferred to buffer Aϩ (60 mM KCl, 15 mM NaCl, 13 mM EDTA, 0.1 mM EGTA, 15 mM Tris-HCl (pH 7.4), 0.5 mM DTT, 0.5% NP-40), and disrupted in a ground glass homogenizer. Nuclei were further dissociated using a homogenizer fitted with pestle B and the suspension was filtered through two layers of Miracloth. The filtrate was layered onto a sucrose cushion (60 mM KCl, 15 mM NaCl, 1 mM EDTA, 0.1 mM EGTA, 15 mM Tris-HCl, pH 7.4, 0.5 mM DTT, 0.3 M sucrose) and centrifuged. The pellet was resuspended and dissociated in a Dounce fitted with pestle A and layered over another sucrose cushion. Nuclei were harvested by centrifugation of the homogenate at 700g at 4°C for 5 min and processed for immunoblotting as described above.
In Vitro Primary Cultures and Drug Treatments
Four-to 5-h-old embryos were dechorionated, rinsed extensively with water, washed twice with 95% ethanol (total 5 min), and washed twice in 4 ml culture medium (SM: Schneider's medium supplemented with 2% fetal calf serum (Gibco)). Embryos were dissociated in a loose-fitting Dounce in 5 ml SM. The cells were passed through a Nitex screen to remove large debris and centrifuged in an IEC swinging bucket rotor at setting 5 for 5 min at 4°C. The pellet was washed three times by resuspension in 5 ml media and centrifuged as described above, and then 0.5 ml was plated onto a clean glass coverslips and allowed to settle for 30 min at 25°C. Then 1.5 ml medium was added (with or without 5 g/ml colcemid), and the cells were cultured for 2-4 h. Following culture, cells were either fixed in 3.7% formaldehyde and processed for immunofluorescence or scraped, pelleted, and processed for 2-D immunoblots.
RESULTS
Developmental Regulation of Multiple Prospero Protein Isoforms
The prospero transcript is alternatively spliced to encode two proteins: ProsL protein (1403 amino acids, predicted 165 kDa) and ProsS protein (1374 amino acids, predicted 160 kDa) . The extra 29 aa in ProsL are at the beginning of the homeodomain, and thus both ProsS and ProsL should be recognized by our N-and C-terminal monoclonals (see below). To identify Prospero isoforms and determine their developmental profile, we performed Western blots on hand-picked, staged embryos ( Fig. 1) . We observe abundant Prospero protein isoforms at 220 and 210 kDa and lower levels of protein migrating at 144 kDa (Fig. 1) . The 220-kDa isoform is present in stage 1-3 embryos and ovaries (Figs. 1a and 1b) , suggesting that it is maternally inherited; isoforms of this size are detected throughout embryogenesis. The 210-kDa band first becomes abundant at stage 7 (Fig. 1a) , with levels steadily increasing at subsequent stages of development. The 144-kDa band appears at stage 9 (Fig. 1a ) and persists at low levels at later stages. In addition, we occasionally see a faint band at 165 kDa in some experiments (Fig. 1a) .
The 220-, 210-, and 144-kDa isoforms are recognized by two independent Prospero monoclonal antibodies: the MR1a mouse monoclonal recognizing a C terminal epitope (Fig. 1a) and the P3D4 rat monoclonal recognizing an N terminal epitope (Fig. 1b) . In addition, these bands are specifically absent in old (stage 17) embryos homozygous for a prospero null allele (Fig. 2) . We conclude that prospero encodes multiple protein isoforms; the major two isoforms migrate slower than predicted, and the minor isoform migrates faster than predicted.
Prospero Is a Phosphoprotein
The appearance of Prospero isoforms that migrate more slowly than predicted by sequence analysis suggests that some Prospero protein may be posttranslationally modified. To determine if Prospero is phosphorylated, we subjected Prospero protein to phosphatase treatment and assayed for changes in MW and isoelectric point (pI). Stage 9 -11 embryos were used because all of the Prospero isoforms are present at these stages. Potato acid phosphatase (PAP) treatment for either 40 or 60 min resulted in a loss of the 220-kDa band (Fig. 3A, lanes 1 and 3) ; this is not observed in lysates treated with PAP plus a phosphatase inhibitor (Fig.  3A, lanes 2 and 4) .
A more detailed analysis using two-dimensional immunoblots reveals that each Prospero isoform has a distinct pI in the untreated lysate: the 220-kDa protein migrates around pI 5.0, the 210-kDa protein migrates as a series of spots between pI 5.4 and 6.0, and the 144-kDa protein migrates at pI 5.1. All of these isoforms are more acidic than the predicted pI of 6.0 based on sequence analysis, which is consistent with posttranslational modification by phosphorylation. After phosphatase treatment, the 220-kDa/pI 5.0 isoform is absent (Fig. 3B, arrowhead) , and the 210-kDa/pI 5.6 -6.0 isoforms have lost their most acidic species (Fig. 3B, asterisks) ; these changes are not observed following PAP plus phosphatase inhibitor treatment (Fig. 3B) . We conclude that the 220-kDa/pI 5.0 isoform of is phosphorylated. Surprisingly, the 144-kDa/pI 5.1 isoform is unaffected by PAP treatment, despite its acidic isoelectric point.
Cortical Prospero Is Phosphorylated
Prospero protein can be localized in the nucleus or cytoplasm, or can be membrane-associated (subsequently called "cortical") depending on the stage of development, cell type, and stage of the cell cycle. For example, Prospero is cytoplasmic in early embryos, cortical in mitotic neuroblasts, and nuclear in GMCs. A detailed description of Prospero subcellular localization is given in Spana and Doe (1995) ; here we summarize the differences in Prospero subcellular localization during the course of embryogenesis (Figs. 4A-4F ) and show parallel 2D Western blots of identically staged hand-picked embryos (Figs. 4AЈ-4FЈ) .
In precellular stage 1-5 embryos Prospero protein is cytoplasmic, with perhaps some associated with the embryo cortex (Figs. 4A and 4B) ; 2D Western blot analysis reveals only the acidic 220-kDa/pI 5.0 phosphorylated Prospero isoform (Figs. 4AЈ and 4BЈ ). In cellularized stage 7 embryos Prospero is also cortical or cytoplasmic in the ventral ectoderm and procephalic region (Fig. 4C) , but there are a few cells with nuclear staining in the procephalic region (data not shown). Biochemical analysis reveals the acidic 220-kDa/pI 5.0 isoform, as well as the first appearance of the more basic 210-kDa/pI 5.6 -6.0 isoforms (Fig.  4CЈ) ; over time, this 210-kDa isoform becomes more acidic (phosphorylated). During stages 9 -13, there is basal cortical Prospero at mitosis in neuroblasts, sense organ precursors, and posterior midgut precursors; however, a much larger FIG. 1. Developmental regulation of Prospero protein isoforms. Western blots of embryos at different developmental stages. Hand-picked embryos at the stages shown above each lane were used; ov, ovaries. Molecular weights of the various isoforms are indicated on the right (arrowheads). (a) Embryo lysates probed with monoclonal MR1a (binds a C-terminal Prospero epitope) detects a series of developmentally regulated isoforms of 220, 210, 165, and 144 kDa; the 220-kDa isoform appears to be maternally provided. This exposure was chosen to show that faint bands at 144 and 165 kDa; lighter exposures clearly reveal two bands at 210 and 220 kDa. The 144-kDa isoform is reliably detected at stages 9 -11; it can occasionally be seen at later stages in 1D blots (but less often in 2D blots, see Figs. 4DЈ-4FЈ ). The bottom panel is the lower portion of the blot probed with antitubulin for a loading control. (b) Stage 9 -11 embryo lysates probed with monoclonal P3D4 (binds an N-terminal Prospero epitope) show the same major isoforms. Spana and Doe, 1995) . The corresponding 2D Western blots show persistence of the 220-kDa/pI 5.0 phosphorylated Prospero isoform and a greatly increased level of the 210-kDa/pI 5.4 -6.0 isoforms (Figs. 4DЈ and 4EЈ); in addition, the 144-kDa isoform is reliably detected at these stages (Figs. 1 and 4DЈ ). In stage 15 embryos, the subcellular localization of Prospero is still predominantly nuclear (Fig. 4E) , and we transiently detected a 220-kDa/pI 5.4 -6.0 streak (Fig. 4EЈ) . By stage 17, Prospero protein is essentially restricted to glial nuclei in the CNS and PNS (Fig. 4F) , and 2D Westerns show predominantly the 210-to 220-kDa/pI 5.4 -5.6 isoforms (Fig. 4FЈ) . The latter result suggests that the 210-to 220-kDa/pI 5.4 -5.6 Prospero isoforms constitute some or all of the nuclear Prospero protein. To directly test this hypothesis, we purified nuclei from 3-to 12-h embryos (corresponding to embryos shown in Figs. 4B-4D ) and assayed for Prospero isoforms by 2D Western blot. We find that purified nuclei from these stages contain the 210-kDa/pI 5.4 -6.0 isoforms (Fig. 4GЈ) ; the 220-kDa/pI 5.0 cortical isoform is not present in purified nuclei, although it is easily detectable in whole embryo lysate at these stages (see Figs. 4BЈ-4DЈ) .
FIG. 2. Prospero isoforms are absent in embryos homozygous
To further investigate the phosphorylation state of cortical and nuclear Prospero protein, we used an in vitro neuroblast culture system in which it is possible to bias Prospero localization to the cortex or to the nucleus (Broadus and . In wild-type cultures, Prospero is mostly nuclear (in GMCs and glia) with some mitotic cells showing asymmetric cortical localization (Fig. 5) . As expected, the corresponding 2D Western detects a large amount of the nuclear Prospero isoforms and a small amount of the cortical phosphorylated Prospero isoform (Fig. 5aЈ) . Treatment of the cultures with colcemid, a microtubule-destabilizing drug, arrests cells in mitosis and leads to a dramatic increase in the percentage of cells showing asymmetric cortical Prospero localization ( Fig. 5 ; Broadus and Doe, 1997) . The 2D Western blot of colcemidtreated cultures shows an enrichment of the phosphorylated Prospero isoform at the expense of the nuclear isoforms (Fig. 5bЈ) . This further supports our conclusion that the 220-kDa/pI 5.0 phosphorylated Prospero isoform represents cortical Prospero protein.
We conclude that the 220-kDa/pI 5.0 phosphorylated Prospero isoform represent cortical or cytoplasmic Prospero protein, and the 210-to 220-kDa/pI 5.4 -6.0 isoforms represent nuclear Prospero protein (Table 1 ). The 144-kDa/pI 5.1 isoform is restricted to stages 9 -15, where both cortical and nuclear Prospero proteins are detected, and thus it is not possible to correlate it with a particular subcellular distribution.
Mitosis Is Correlated with, but Not Required for, Prospero Phosphorylation
There are several reasons to consider that phosphorylation of Prospero might be required for its cortical localization: (1) as we have shown, cortical Prospero is highly phosphorylated; (2) cortical localization of Prospero is tightly cell cycle regulated, occurring only at mitosis (Knoblich et al., 1995; Spana and Doe, 1995) , suggesting that mitotic kinases may trigger Prospero localization; and (3) the 235-aa domain of Prospero protein necessary and sufficient for cortical localization (Hirata et al., 1995) contains 24 amino acids that could be phosphorylated: 19 serines, 14 threonines, and 1 tyrosine. To test the possibility that mitotic kinases are necessary for Prospero phos- Stage 9 -11 embryonic extracts were treated with potato acid phosphatase (ϩ), or potato acid phosphatase in the presence of 3 mM sodium vanadate and 20 nM microcystin phosphatase inhibitors (Ϫ) for 40 or 60 min. The 220-kDa species is missing following phosphatase treatment (ϩ lanes). Arrowheads indicate 208-and 144-kDa molecular weight markers. (b) 2D Western analysis of identical samples shown in panel a reveals that phosphatase treatment (ϩ) results in the loss of the 220-kDa/pI 5 isoform (arrowhead) and the more acidic isoforms of the 220-to 210-kDa/pI 5.4 -6.0 streak (asterisks). This overexposure was chosen to clearly show the lack of a 220-kDa/pI 5.0 isoform after phosphatase treatment; lighter exposures reveal the two bands at 210 and 220 kDa. The 144-kDa/pI 5.1 isoform is not affected by phosphatase treatment. Blots were probed with the MR1a C-terminal monoclonal.
FIG. 4.
Cortical Prospero is highly phosphorylated relative to nuclear Prospero. Hand-picked staged embryos were processed for Prosperophorylation and cortical localization, we assayed the phosphorylation state of a mutant Prospero protein that remains persistently cortical throughout interphase in GMCs and neurons. In embryos homozygous for the prospero I13 allele (which results in a single glycine to arginine amino acid substitution in a C-terminal region unrelated to any putative phosphorylation sites or the domain required for cortical localization; C.-Y.P. and C.Q.D., unpublished data), the mutant Prospero protein shows persistent cortical localization in interphase (Fig. 6B ) and an enrichment of the phosphorylated Prospero 220-kDa/pI 5.0 isoform (Fig. 6BЈ) . In contrast, wild-type GMCs and young neurons have nuclear Prospero localization (Fig. 6A ) and lack the phosphorylated Prospero 220-kDa/pI 5.0 isoform (Fig. 6AЈ) . These data show that cortical localization is sufficient for generating or maintaining the phosphorylated Prospero 220-kDa/pI 5.0 isoform. They are most consistent with a model in which phosphorylation is the consequence of cortical localization, but do not formally exclude the possibility that phosphorylation is required for the initial localization of Prospero to the cell cortex (see Discussion).
DISCUSSION
Although a growing number of proteins are known to be unequally partitioned during asymmetric cell division in a wide range of organisms, virtually nothing is known about the role posttranslational modifications play in regulating stability or distribution of these proteins. Here we investigate the role of phosphorylation in regulating the asymmetric localization of Prospero. 
Developmental Regulation of Multiple Prospero Isoforms
The major Prospero isoforms migrate at 210 and 220 kDa, and a less abundant isoform migrates at 144 kDa. Two criteria indicate that these are authentic Prospero isoforms: (1) we detect all three major isoforms with a monoclonal recognizing a C-terminal epitope (mouse MR1a) as well as a monoclonal recognizing an N-terminal epitope (rat P3D4); and (2) all three major isoforms are absent from homozygous prospero null embryos. The anomalous migration of these Prospero isoforms (relative to a predicted migration of around 165 kDa) could be due to posttranslational modifications, to an unusual conformation of the proteins during electrophoresis, or both. We detect the 220-kDa Prospero isoform in ovaries and in stage 1-3 embryos, suggesting that the early embryo contains maternally provided Prospero protein. Removal of prospero expression in the germline will be necessary to determine the function, if any, of the maternal Prospero protein.
Phosphorylation and Cortical Localization of Prospero
Both the ProsL and ProsS proteins are predicted to have an isoelectric point of about 6.0, but all of the Prospero isoforms have a more acidic isoelectric point (they range from 5.0 to 6.0), suggesting that they may be phosphorylated. Phosphatase treatment of embryonic lysates shows that the 220-kDa/pI 5.0 isoform is phosphorylated, as well as the more acidic species within the 210-to 220-kDa/pI 5.4 -6.0 streak. However, the acidic 144-kDa/pI 5.1 isoform and the 210-to 220-kDa Prospero isoforms between pI 5.6 and 6.0 are resistant to phosphatase treatment. These isoforms may contain phosphate groups resistant to phosphatase treatment, or they may be nonphosphorylated isoforms that migrate anomalously.
Prospero protein contains a homeodomain, regulates gene expression, and can act as a transcriptional activator or repressor in vitro (Hassan et al., 1997) . Consistent with these molecular and functional attributes, Prospero protein is localized to the nucleus in many cell types. However, Prospero protein also shows unexpected membrane association (cortical localization) in mitotic precursors of the CNS, PNS, and gut (Hirata et al., 1995; Knoblich et al., 1995; Spana and Doe, 1995) . We find that phosphorylated Prospero protein (220-kDa/pI 5.0 isoform) is always correlated with cortical localization, whereas dephosphorylated Prospero protein (210-to 220-kDa/pI 5.4 -6.0 isoforms) is correlated with nuclear localization. This correlation is observed in staged embryos (Fig. 4) , following subcellular fractionation (Fig. 4) , following in vitro culture of wild-type and mitotically arrested neuroblasts (Fig. 5) , or in homozygous prospero I13 mutant embryos (Fig. 6) . In contrast, the 144-kDa/pI 5.0 isoform is expressed in embryos showing either cortical Prospero or nuclear Prospero, or both, and thus we are unable to correlate this isoform with a particular subcellular distribution.
Function of Prospero Phosphorylation
Recent reports show that cortical localization of Prospero requires Miranda, a predicted coiled-coil protein that is colocalized with Prospero at the basal cortex of dividing neuroblasts (Ikeshima-Kataoka et al., 1997; Shen et al., 1997 Shen et al., , 1998 . Prospero binds Miranda in yeast two hybrid and column assays, and thus Miranda is thought to anchor Prospero at the cell cortex. Degradation of Miranda in the GMC is correlated with release of Prospero from the cortex, and Prospero then enters the GMC nucleus (IkeshimaKataoka et al., 1997) . The results presented in this paper show that cortical Prospero (presumably bound to Miranda) is highly phosphorylated. However, our results do not provide information on the function of phosphorylation in regulating Prospero-Miranda binding or their cortical localization. Our data are consistent with the following models:
(1) Phosphorylation of Prospero is required for Miranda binding and cortical localization. In this model, kinasemediated phosphorylation of Prospero would have to be very rapid, and/or occur during mitosis, to prevent Prospero from entering the neuroblast nucleus.
(2) Phosphorylation of Prospero is a consequence of Miranda binding and cortical localization. In this model, a dephosphorylated isoform of Prospero binds to Miranda, and this association results in the phosphorylation of Prospero by a Miranda-or cortex-associated kinase. In this model, the phosphorylation of Prospero may be required to stabilize the Prospero-Miranda interaction, or for events "downstream" of Prospero-Miranda binding, such as facilitating Miranda degradation, release of Prospero from Miranda, or Prospero nuclear localization.
Distinguishing which of the above two models is correct will require site-directed mutagenesis of the candidate phosphorylation sites within the Prospero protein. It may be that bulk phosphorylation events, such as described in this paper, all contribute incrementally to a particular function. In this case, mutations of individual amino acids may lead to a very subtle phenotype. A more likely possibility is that phosphorylation of certain amino acids is critical for a particular function, whereas other sites are unimportant. The minimal domain of Prospero required for asymmetric localization is 235 amino acids (709 -943; Hirata et al., 1995) ; phosphorylatable residues in this domain would be the best candidates for mutagenesis.
